DJO Global Inc. announced in a company press release that it has signed an exclusive distribution agreement with Exos Corporation, providing DJO with exclusive rights to sell Exos’ upper extremity products in North and South America. Terms of the distribution agreement were not disclosed in the release. The agreement commences October 1.
“It has always been DJO’s passion to identify innovative solutions to improve patient outcomes while controlling overall healthcare costs,” Mike Mogul, president and chief executive officer of DJO Global, stated in the release. “Exos’ unique technology will enable DJO to market their next generation of upper extremity bracing and supports products now, while providing us with an impressive array of future opportunities.”
Based in Arden Hills, MN, Exos Corporation is a medical device company focused on a thermoformable external musculoskeletal stabilization system. The company has filed several patents for the application, materials and construction of its products and is continuously adding to its intellectual property portfolio.
Exos is the only thermoformable bracing system, offering a waterproof, removable, adjustable and reformable solution for the treatment of fractures and other injuries requiring stabilization. This technology, according to the release, has the opportunity to dramatically change clinical practices for external musculoskeletal support and stabilization.
